Matthew Goff Investment Advisor’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Hold
3,615
0.06% 82
2026
Q1
$313K Buy
+3,615
New +$316K 0.05% 97
2025
Q4
Sell
-3,615
Closed -$262K 96
2025
Q3
$262K Hold
3,615
0.04% 87
2025
Q2
$237K Hold
3,615
0.04% 90
2025
Q1
$255K Hold
3,615
0.05% 97
2024
Q4
$238K Hold
3,615
0.04% 95
2024
Q3
$255K Hold
3,615
0.05% 96
2024
Q2
$240K Hold
3,615
0.05% 91
2024
Q1
$245K Hold
3,615
0.05% 88
2023
Q4
$223K Hold
3,615
0.05% 87
2023
Q3
$213K Hold
3,615
0.05% 87
2023
Q2
$216K Hold
3,615
0.05% 90
2023
Q1
$211K Hold
3,615
0.05% 88
2022
Q4
$224K Hold
3,615
0.06% 82
2022
Q3
$204K Hold
3,615
0.06% 76
2022
Q2
$231K Hold
3,615
0.06% 74
2022
Q1
$234K Hold
3,615
0.05% 74
2021
Q4
$241K Hold
3,615
0.06% 74
2021
Q3
$221K Hold
3,615
0.05% 86
2021
Q2
$224K Hold
3,615
0.06% 85
2021
Q1
$214K Hold
3,615
0.06% 86
2020
Q4
$216K Buy
+3,615
New +$206K 0.06% 80
2018
Q4
Sell
-3,615
Closed -$202K 54
2018
Q3
$202K Sell
3,615
-13,731
-79% -$750K 0.08% 66
2018
Q2
$678K Buy
+17,346
New +$860K 0.27% 49

Other funds holding IHE

Matthew Goff Investment Advisor's IHE Position: Q2 2026 in Review

Matthew Goff Investment Advisor held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,615 shares worth $358K. The position accounts for 0.06% of the portfolio, ranked #82.

Matthew Goff Investment Advisor first reported a position in IHE in Q2 2018 and has held it in 24 quarters since. The position peaked at $678K in Q2 2018. 50 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Matthew Goff Investment Advisor held 3,615 shares of iShares US Pharmaceuticals ETF worth $358K as of Q2 2026.
  • Matthew Goff Investment Advisor left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.06% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #82 holding.
  • Matthew Goff Investment Advisor first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and has held it in 24 quarters since.
  • Matthew Goff Investment Advisor's iShares US Pharmaceuticals ETF position peaked at $678K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.